Provided by Tiger Trade Technology Pte. Ltd.

ZyVersa Therapeutics, Inc.

0.1600
-0.0200-11.11%
Volume:126.62K
Turnover:22.71K
Market Cap:1.30M
PE:-0.03
High:0.2000
Open:0.1800
Low:0.1600
Close:0.1800
52wk High:1.94
52wk Low:0.1100
Shares:8.10M
Float Shares:7.67M
Volume Ratio:2.54
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6800
EPS(LYR):-8.4803
ROE:-112.65%
ROA:-46.30%
PB:-0.11
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
ZyVersa Therapeutics, Inc.
Exchange:
OTCQB
Establishment Date:
2014
Employees:
7
Office Location:
2200 N. Commerce Parkway,Suite 208,Weston,Florida,United States
Zip Code:
33326
Fax:
- -
Introduction:
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is headquartered in Weston, Florida.